167 related articles for article (PubMed ID: 8721109)
1. [Cancer diagnosis with positron emission tomography (PET)].
Kubota K
Kaku Igaku; 1996 Feb; 33(2):207-12. PubMed ID: 8721109
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of early cancer with positron emission tomography].
Kubota K
Nihon Rinsho; 1996 May; 54(5):1263-7. PubMed ID: 8965348
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of lung tumor with positron emission tomography: a prospective study.
Kubota K; Matsuzawa T; Fujiwara T; Ito M; Hatazawa J; Ishiwata K; Iwata R; Ido T
J Nucl Med; 1990 Dec; 31(12):1927-32. PubMed ID: 2266388
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography in oncology.
Leskinen-Kallio S
Clin Physiol; 1994 May; 14(3):329-35. PubMed ID: 8026150
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography in oncology: the most sophisticated imaging technology.
Lacić M; Maisey MN; Kusić Z
Acta Med Croatica; 1997; 51(1):1-9. PubMed ID: 9115096
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
[TBL] [Abstract][Full Text] [Related]
8. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.
Ogawa T; Inugami A; Hatazawa J; Kanno I; Murakami M; Yasui N; Mineura K; Uemura K
AJNR Am J Neuroradiol; 1996 Feb; 17(2):345-53. PubMed ID: 8938309
[TBL] [Abstract][Full Text] [Related]
9. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
10. [Potential use of positron-emission tomography in clinical oncology].
Fukuda H; Matsuzawa T; Tateno Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):860-5. PubMed ID: 3291774
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
12. Use of positron emission tomography in oncology.
Glaspy JA; Hawkins R; Hoh CK; Phelps ME
Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
[TBL] [Abstract][Full Text] [Related]
13. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
14. PET for diagnosis of malignant lymphoma of the scalp: comparison of [11C]methyl-L-methionine and [18F]fluoro-2-deoxyglucose.
Tsuyuguchi N; Hakuba A; Okamura T; Ochi H; Suzuki T; Sunada I
J Comput Assist Tomogr; 1997; 21(4):590-3. PubMed ID: 9216763
[TBL] [Abstract][Full Text] [Related]
15. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
[TBL] [Abstract][Full Text] [Related]
16. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.
Yamada Y; Uchida Y; Tatsumi K; Yamaguchi T; Kimura H; Kitahara H; Kuriyama T
J Nucl Med; 1998 Jul; 39(7):1160-6. PubMed ID: 9669387
[TBL] [Abstract][Full Text] [Related]
17. PET FDG studies in oncology.
Hawkins RA; Hoh CK
Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET.
Sasaki M; Kuwabara Y; Ichiya Y; Akashi Y; Yoshida T; Nakagawa M; Murayama S; Masuda K
J Nucl Med; 1999 Oct; 40(10):1595-601. PubMed ID: 10520697
[TBL] [Abstract][Full Text] [Related]
19. PET and [18F]-FDG in oncology: a clinical update.
Conti PS; Lilien DL; Hawley K; Keppler J; Grafton ST; Bading JR
Nucl Med Biol; 1996 Aug; 23(6):717-35. PubMed ID: 8940714
[TBL] [Abstract][Full Text] [Related]
20. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]